Metropolis Healthcare Ltd.Metropolis Healthcare Ltd.Metropolis Healthcare Ltd.

Metropolis Healthcare Ltd.

No trades
Last report date
May 13, 2026
Report period
Q4 2025
EPS
2.50INR
Revenue
‪4.25 B‬INR
Market capitalization
‪109.87 B‬INR
9.15INR
‪1.90 B‬INR
‪16.46 B‬INR
‪106.02 M‬
Beta (1Y)
0.64

About Metropolis Healthcare Ltd.


CEO
Surendran Chemmenkotil
Headquarters
Mumbai
Founded
1981
IPO date
Apr 15, 2019
Identifiers
2
ISIN INE112L01020
CFI code
ESVUFN
Metropolis Healthcare Ltd. engages in the provision of medical laboratories. It operates through the India and Outside India geographical segments. It offers comprehensive testing in the areas of genetics biochemistry, molecular oncology, anatomic pathology, microbiology, hematology, and immunochemistry. The company was founded by Sushil Kanubhai Shah and Gomathi Babu Sadacharam Kulandai Velu in 1981 and is headquartered in Mumbai, India.

Check out other big names from the same industry as METROPOLIS.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Weight 0.02%
Market value ‪1.95 M‬
Weight 0.16%
Market value ‪1.00 M‬
Weight 0.05%
Market value ‪783.64 K‬
Weight 0.04%
Market value ‪295.68 K‬
Weight 0.36%
Market value ‪189.18 K‬
Weight 0.04%
Market value ‪186.78 K‬
Weight 1.10%
Market value ‪143.18 K‬
Weight 0.02%
Market value ‪70.96 K‬
Weight 0.03%
Market value ‪35.75 K‬

Explore more ETFs 

Frequently asked questions


The current price of METROPOLIS is 529.95 INR — it has decreased by −2.19% in the past 24 hours. Watch Metropolis Healthcare Ltd. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BSE exchange Metropolis Healthcare Ltd. stocks are traded under the ticker METROPOLIS.
METROPOLIS stock has risen by 3.41% compared to the previous week, the month change is a 12.80% rise, over the last year Metropolis Healthcare Ltd. has showed a 32.49% increase.
We've gathered analysts' opinions on Metropolis Healthcare Ltd. future price: according to them, METROPOLIS price has a max estimate of 715.00 INR and a min estimate of 500.00 INR. Watch METROPOLIS chart and read a more detailed Metropolis Healthcare Ltd. stock forecast: see what analysts think of Metropolis Healthcare Ltd. and suggest that you do with its stocks.
METROPOLIS reached its all-time high on Dec 30, 2021 with the price of 894.75 INR, and its all-time low was 226.20 INR and was reached on May 14, 2019. View more price dynamics on METROPOLIS chart.
See other stocks reaching their highest and lowest prices.
METROPOLIS stock is 5.03% volatile and has beta coefficient of 0.64. Track Metropolis Healthcare Ltd. stock price on the chart and check out the list of the most volatile stocks — is Metropolis Healthcare Ltd. there?
Today Metropolis Healthcare Ltd. has the market capitalization of ‪109.87 B‬, it has increased by 1.43% over the last week.
Yes, you can track Metropolis Healthcare Ltd. financials in yearly and quarterly reports right on TradingView.
Metropolis Healthcare Ltd. is going to release the next earnings report on Aug 7, 2026. Keep track of upcoming events with our Earnings Calendar.
METROPOLIS earnings for the last quarter are 2.50 INR per share, whereas the estimation was 2.57 INR resulting in a −2.84% surprise. The estimated earnings for the next quarter are 2.63 INR per share. See more details about Metropolis Healthcare Ltd. earnings.
Metropolis Healthcare Ltd. revenue for the last quarter amounts to ‪4.25 B‬ INR, despite the estimated figure of ‪4.26 B‬ INR. In the next quarter, revenue is expected to reach ‪4.38 B‬ INR.
METROPOLIS net income for the last quarter is ‪509.03 M‬ INR, while the quarter before that showed ‪413.86 M‬ INR of net income which accounts for 0.00% change. Track more Metropolis Healthcare Ltd. financial stats to get the full picture.
Yes, METROPOLIS dividends are paid semi-annually. The last dividend per share was 4.00 INR. As of today, Dividend Yield (TTM)% is 0.19%. Tracking Metropolis Healthcare Ltd. dividends might help you take more informed decisions.
Metropolis Healthcare Ltd. dividend yield was 0.46% in 2025, and payout ratio reached 21.76%. The year before the numbers were 0.00% and 0.00% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Metropolis Healthcare Ltd. EBITDA is ‪4.01 B‬ INR, and current EBITDA margin is 24.36%. See more stats in Metropolis Healthcare Ltd. financial statements.
Like other stocks, METROPOLIS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Metropolis Healthcare Ltd. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Metropolis Healthcare Ltd. technincal analysis shows the buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Metropolis Healthcare Ltd. stock shows the strong buy signal. See more of Metropolis Healthcare Ltd. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.